Stockreport

Akari Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Clinical Progress

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF Received Regulatory Clearance in Europe to Open First Clinical Trial Site for Phase III PNH Naïve TrialCAPSTONE, the Phase III Naïve PNH Trial Expected to Open in Q1 201 [Read more]